1980
DOI: 10.1007/978-3-642-67397-9_4
|View full text |Cite
|
Sign up to set email alerts
|

Methods for the Examination of Ganglion-Blocking Activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

1986
1986
2017
2017

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 115 publications
0
7
0
Order By: Relevance
“…Inhibition was absent or only very weak. In contrast, application of the nicotinic agonist DMPP (Chen et al, 1951;see Table 2 in Gyermek, 1980) (1 mM; n = 7) caused excitation followed by prolonged inhibition (Fig. 2B).…”
Section: Applicationmentioning
confidence: 87%
“…Inhibition was absent or only very weak. In contrast, application of the nicotinic agonist DMPP (Chen et al, 1951;see Table 2 in Gyermek, 1980) (1 mM; n = 7) caused excitation followed by prolonged inhibition (Fig. 2B).…”
Section: Applicationmentioning
confidence: 87%
“…The blocking action of mecamylamine is exerted on all native subtypes of nAChRs despite their different subunit composition (Connolly et al, 1992). In vivo mecamylamine lowers blood pressure and can prevent seizures induced experimentally with the use of nicotine (Gyermek, 1980). In view of this widespread action, which remains, however, highly selective against nAChRs, mecamylamine is commonly used to probe the role of such receptors in central and peripheral synaptic transmission processes.…”
mentioning
confidence: 99%
“… 5 Mecamylamine hydrochloride is a secondary amine and a well characterized post-ganglionic sympathetic system inhibitor that has been shown to block nicotine-induced stimulation of nAChRs and was extensively used as an antihypertensive. 16 19 Studies in mammalian brain and amphibian neuromuscular tissue demonstrated that mecamylamine is a noncompetitive inhibitor that binds to the nAChR ion channel region and decreases the longevity of channel opening rather than by blocking nicotine binding. 20 , 21 Mecamylamine is a highly lipophilic small molecule with an excellent biodistribution profile that makes it an excellent candidate for topical administration.…”
mentioning
confidence: 99%